openPR Logo
Press release

Genomic Health, Inc. (GHDX) - Product Pipeline Analysis

Genomic Health, Inc. (GHDX) - Product Pipeline Analysis

Genomic Health, Inc. (Genomic Health) is a life science company focused on the research, development and commercialization of genomic-based clinical laboratory services for the treatment of cancer. The company is focused on improving the quality of treatment decisions for cancer patients by offering individualized information to patients and their physicians through the genomic analysis of tumor biopsies. The company’s Oncotype DX platform uses quantitative genomic analysis in standard tumor pathology specimens for providing tumor-specific information. Its key products include Oncotype DX breast cancer test and Oncotype DX colon cancer test. Genomic Health is headquartered at Redwood City in California, the US.

This report is a source for data, analysis and actionable intelligence on the Genomic Health, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

For more information kindly visit : http://www.companyprofilesandconferences.com/report/Genomic-Health-Inc-GHDX-Product-Pipeline-Analysis.html

Or

Contact us at :

Company Profiles and Conferences
Tel: +91 22 2756 1536
Fax: +91 22 2757 9131
Email: info@companyprofilesandconferences.com
Website: www.companyprofilesandconferences.com

Search thousands of company profiles, SWOT analysis reports and company financials. Search by industry sector, or simply search all company profiles by company name. companyprofilesandconferences.com contains one of the world's largest collections of company insight and company profiles from leading global market report publishers and analysts. Global brands rely on companyprofilesandconferences.com for their strategic company insight and company profile needs.

Flat A-1901/02, 19th floor, Kshitij Building, Plot-3,
Sec-19, Palm Beach Road, Sanpada,
Navi Mumbai - 400705, India.
Phone : +91 22 2756 1536

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genomic Health, Inc. (GHDX) - Product Pipeline Analysis here

News-ID: 205890 • Views:

More Releases from Company Profiles and Conferences

NextEra Energy, Inc. (NEE) - Financial and Strategic SWOT Analysis Review
NextEra Energy, Inc. (NEE) - Financial and Strategic SWOT Analysis Review Summary NextEra Energy, Inc. (NextEra) is a publicly traded utility and gas company. It engages in the provision of electricity and other related products and services in the US. The company operates business through its two subsidiaries, namely, Florida Power & Light Company (FPL); and NextEra Energy Resources, LLC (NextEra Energy Resources). FPL is an electric utility company, supplying power
Thai Unique Coil Center PCL (TUCC) - Financial and Strategic SWOT Analysis Revie …
Thai Unique Coil Center PCL (TUCC) - Financial and Strategic SWOT Analysis Review This comprehensive SWOT profile of Thai Unique Coil Center PCL provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies
AngioDynamics, Inc. (ANGO) - Product Pipeline Analysis
AngioDynamics, Inc. (ANGO) - Product Pipeline Analysis AngioDynamics, Inc. (AngioDynamics), a public medical device company, is engaged in designing, developing, manufacturing and marketing therapeutic and diagnostic devices for the treatment of peripheral vascular disease (PVD) and other non-coronary diseases. It focuses on the development of innovative, minimally invasive, image-guided procedures to treat PVD and oncology therapy options including radiofrequency ablation, systems, irreversible electroporation, surgical resection systems and embolization products for the

All 4 Releases


More Releases for Genomic

Emerging Trends Influencing The Growth Of The Genomic Biomarker Market: Technolo …
The Genomic Biomarker Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Genomic Biomarker Market Size Expected to Be by 2034? The size of the genomic biomarker market has witnessed swift expansion in the recent past. It is slated to expand from a
Top Factor Driving Genomic Biomarker Market Growth in 2025: Impact of Chronic Di …
How Big Is the Genomic Biomarker Market Expected to Be, and What Will Its Growth Rate Be? The size of the genomic biomarker market has seen a swift expansion in recent times. It's expected to increase from $8.4 billion in 2024 to $9.9 billion in 2025, growing at a compound annual growth rate (CAGR) of 18.0%. The historic period growth can be credited to the growing awareness about genetic disorders, heightened
Genomic Biomarker Market Future Business Opportunities 2025-2032 | Liquid Genomi …
Latest Report, titled "Genomic Biomarker Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Genomic Biomarker market has been expanding significantly
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the
Genomic Biomarkers Market 2022 | Detailed Report
The research reports on “Genomic Biomarkers Market” report gives detailed overview of factors that affect global business scope. Genomic Biomarkers Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5334064 The
Latest Survey on Genomic Medicine Market 2019 by Key Companies Overview-BioMed C …
The recently published report called “Global Genomic Medicine Market 2019” offers a brief overview of the Genomic Medicine market across the globe. The research report showcases innovative tool for evaluating the complete scenario of the Genomic Medicine market with its tactical decision making, opportunities and supporting strategic. Furthermore, the report also analyses the competitive analysis as well as changing trends which becomes most crucial in order to monitor the performance